Teleflex Announces Quarterly Dividend
Teleflex (NYSE: TFX) has announced a quarterly cash dividend of $0.34 per share, payable on March 15, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teleflex (NYSE: TFX) has announced a quarterly cash dividend of $0.34 per share, payable on March 15, 2023. Shareholders of record as of March 3, 2023 will receive this dividend. Teleflex is dedicated to delivering innovative medical technologies aimed at enhancing healthcare quality and outcomes. Their product range spans multiple sectors, including vascular access, interventional cardiology, and anesthesia. This dividend declaration reflects the company's commitment to returning value to its shareholders while supporting ongoing business growth.
Positive
- Quarterly dividend of $0.34 per share indicates strong cash flow and shareholder return.
- Commitment to innovation in medical technologies may support long-term growth.
Negative
- None.
Details
News Market Reaction – TFX
The recorded move for TFX in the trading session of this news was -2.07%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WAYNE, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents (
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, QuikClot®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.
Contacts:
Teleflex Incorporated
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
John Hsu, CFA
Vice President, Investor Relations
investor.relations@teleflex.com
610-948-2836
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.